Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells
Cervical cancer is the second most common cause of cancer death in women worldwide. Lysophosphatidic acid (LPA) level has been found significantly increased in the serum of patients with ovarian, cervical, and colon cancers. LPA level in cervical cancer patients is significantly higher than in healt...
Main Authors: | Yanxia Sui, Ya Yang, Ji Wang, Yi Li, Hongbing Ma, Hui Cai, Xiaoping Liu, Yong Zhang, Shufeng Wang, Zongfang Li, Xiaozhi Zhang, Jiansheng Wang, Rui Liu, Yanli Yan, Chaofan Xue, Xiaowei Shi, Li Tan, Juan Ren |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/598386 |
Similar Items
-
Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
by: Bicheng Yang, et al.
Published: (2017-11-01) -
Lysophosphatidic Acid Induces Apoptosis of PC12 Cells Through LPA1 Receptor/LPA2 Receptor/MAPK Signaling Pathway
by: Jie Zhang, et al.
Published: (2020-02-01) -
Sonophoresis Enhanced Transdermal Delivery of Cisplatin in the Xenografted Tumor Model of Cervical Cancer
by: Ma S, et al.
Published: (2020-01-01) -
Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo
by: Zi-Li Yu, et al.
Published: (2018-01-01) -
MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin.
by: Xin Zhang, et al.
Published: (2015-01-01)